Humana AB (publ) (STO:HUM)
Sweden · Delayed Price · Currency is SEK 62.70
+0.30 (0.48%)
Aug 14, 2026, 5:29 PM CET
Humana AB Market Cap
Humana AB has a market cap or net worth of 2.98 billion as of August 14, 2026. Its market cap has increased by 49.08% in one year.
Market Cap
2.98B
Enterprise Value
7.13B
Revenue
10.04B
Ranking
n/a
PE Ratio
17.37
Stock Price
62.70
ChartMarket Cap Chart
Since March 22, 2016, Humana AB's market cap has decreased from 3.40B to 2.98B, a decrease of -12.24%. That is a compound annual growth rate of -1.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 2.98B | 20.12% |
| Dec 30, 2025 | 2.48B | 34.25% |
| Dec 30, 2024 | 1.85B | 37.23% |
| Dec 29, 2023 | 1.35B | -26.88% |
| Dec 30, 2022 | 1.84B | -48.20% |
| Dec 30, 2021 | 3.55B | 18.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 153.29B |
| Getinge AB | 65.18B |
| Sectra AB | 53.95B |
| Camurus AB | 37.07B |
| Hansa Biopharma AB | 4.17B |
| CellaVision AB | 3.63B |
| Egetis Therapeutics AB | 3.36B |
| Vicore Pharma Holding AB | 3.31B |